• Biologics in COPD: Why, when, and who

  • May 31 2024
  • Length: 23 mins
  • Podcast

Biologics in COPD: Why, when, and who  By  cover art

Biologics in COPD: Why, when, and who

  • Summary

  • Dr. Jamie Rutland discusses the role of biologic therapy in COPD. He explains that type 2 inflammation, characterized by the presence of eosinophils, is a key factor in COPD. He also discusses the use of biologics to target this inflammation and reduce exacerbations in COPD patients.

    Show more Show less
activate_primeday_promo_in_buybox_DT

What listeners say about Biologics in COPD: Why, when, and who

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.